Stage IV Ovarian Cancer Completed Phase 3 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0030167 (Stage IV Ovarian Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00262847Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerTreatment
NCT00011986Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal CancerTreatment
NCT02311907Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerSupportive Care